The Food and Drug Administration yesterday issued a plan and related guidance outlining how it will implement certain aspects of the Drug Quality and Security Act relevant to drug compounding outsourcing facilities and compounding pharmacies. The plan details how the FDA will address manufacturing standards for outsourcing facilities; regulate compounding from bulk drug substances; restrict compounding of drugs that are essentially copies of FDA-approved drugs; solidify the FDA’s partnership with state regulatory authorities; and provide guidance on other activities that compounders undertake. In other news yesterday, the FDA issued draft guidance clarifying its policy on public warning and notification of recalled products, including drugs, medical devices and cosmetics. Specifically, the guidance outlines circumstances when a company should issue a public warning about a recall; describes the general timeline for companies to issue such a warning; discusses what information should be included in a public warning; and describes situations where the FDA may take action to issue its own public warning should a company’s warning be deemed insufficient.

Related News Articles

Headline
Hospitals spend close to $360 million each year to manage drug shortages, according to a study released this week by Vizient Inc.
Headline
The Centers for Disease Control and Prevention this week announced an anticipated shortage of Aplisol, one of two TB skin tests licensed by the Food and Drug…
Headline
A federal court in Texas yesterday ordered Pharm D Solutions to stop producing or distributing compounded drugs intended to be sterile until the company…
Headline
The Food and Drug Administration Friday issued final guidance clarifying how sponsors may show that a proposed biosimilar product is interchangeable with a…
Headline
The House Judiciary Committee yesterday approved by voice vote the Creating and Restoring Equal Access to Equivalent Samples Act (H.R. 965).
Headline
Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.